Olix Pharmaceuticals Inc.

Olix Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the research and development of RNA interference (RNAi) therapeutics. The company's primary focus is on creating innovative drug solutions aimed at silencing disease-causing genes, which has the potential to treat a wide range of genetic disorders and other challenging health conditions. Olix leverages its proprietary asymmetric RNAi technology, which differentiates it in the biotechnology sector by offering enhanced stability and efficacy compared to traditional siRNA approaches. Operating chiefly in the healthcare and life sciences industry, Olix Pharmaceuticals collaborates with academic institutions and global pharmaceutical companies to advance its therapeutic pipeline. The firm's work underscores a significant advancement in personalized medicine, aiming to offer targeted therapies for conditions that have been traditionally difficult to treat. Through its pioneering research, Olix Pharmaceuticals plays a vital role in transforming treatment paradigms and contributing to the evolving landscape of biotechnological innovations.

CEO

이동기

Employees

66

Website

olixpharma.com